Copyright © 1999 by the European Society of Cardiology.
Idiopathic atrial fibrillation as a risk factor for mortality.The Paris Prospective Study I
a Service de Cardiologie, Hopital Boucicaut, Paris, France
b Unité INSERM 258, Hopital Paul Brousse, Villejuif, France
revised November 3, 1998; accepted November 4, 1998
Abstract
Aims Idiopathic atrial fibrillation describes atrial fibrillation of unknown origin occurring without heart disease. Mortality is considered unaffected by idiopathic atrial fibrillation. We used the long follow-up period (23 years on average) of the Paris Prospective Study I to assess the mortality of idiopathic atrial fibrillation subjects in middle-aged men.
Methods 7746 working Frenchmen, aged 43–52 in 1967–72, underwent a physical examination plus ECG, answered questionnaires, and provided blood samples. Strict exclusion criteria were used to select idiopathic atrial fibrillation only, and men with known cardiac disease were further excluded from analysis. At 1 January 1994, vital status was unknown for 4·6% of the subjects. The analysis was conducted on the 6722 remaining subjects.
Results Twenty-five subjects had idiopathic atrial fibrillation at inclusion. The relative risk (and 95% confidence interval) associated with idiopathic atrial fibrillation was 4·22 [2·10–8·47] for cardiovascular mortality (P=0·0001) and 1·97 [1·14–3·40] for total mortality (P=0·01). When age, systolic blood pressure, cholesterol, body mass index and tobacco consumption were entered into a Cox model, idiopathic atrial fibrillation remained an independent risk factor for cardiovascular (P=0·0008) and total death (P=0·04).
Conclusion With a long follow-up period, idiopathic atrial fibrillation was associated with higher mortality in middle aged Frenchmen.
Key Words: Idiopathic atrial fibrillation • mortality
f1 Correspondence : Xavier Jouven, Service de Cardiologie, Hopital Boucicaut, 78 rue de la convention, 75015 Paris, France.
References
- Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol. 1990;15:1279–1285[Abstract]
- Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H, Sprint study group. Long-Term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J. 1992;13:45–50
[Abstract/Free Full Text] - Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. 1991;84:40–48
[Abstract/Free Full Text] - Lin HJ, Wolf PA, Kelly-Hayes M. Stoke severity in atrial fibrillation. The Framingham Study. Stroke. 1996;27:1760–1764
[Abstract/Free Full Text] - Önundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson T. Chronic atrial fibrillation-epidemiologic features and 14 year follow-up: a case control study. Eur Heart J. 1987;8:521–527
[Abstract/Free Full Text] - Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. N Engl J Med. 1982;306:1018–1022[Abstract]
- Goldberg RJ, Seeley D, Becker RC. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction a community-wide perspective. Am Heart J. 1990;119:996–1001[CrossRef][ISI][Medline]
- Psaty BM, Manolio TA, Kuller LH. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455–2461
[Abstract/Free Full Text] - Thornton JR. Atrial fibrillation in healthy non alcoholic people after an alcoholic binge. Lancet. 1984;2:1013–1015[ISI][Medline]
- Kulbertus HE. Implications of idiopathic atrial fibrillation/flutter in the context of cardiovascular fitness to fly. Eur Heart J. 1992;13 (Suppl H):136–138
- Frothingham C. The Auricles in cases of auricular fibrillation. Arch Int Med. 1925;36:437
- Yater WM. Pathologic changes in Auricular Fibrillation and in allied arrhythmias. Arch Int Med. 1929;43:808
- Neufeld HN, Wagenvoort CA, Burchell HB, Edwards JE. Idiopathic atrial fibrillation. Am J Cardiol. 1961;8:193–197[CrossRef][ISI][Medline]
- Evans W, Swann P. Idiopathic auricular fibrillation. Br Heart J. 1954;16:189–194
[Free Full Text] - Willius FA, Dry TJ. The prognosis of auricular fibrillation of undetermined origin. JAMA. 1941;11:330–332
- Lamb LE, Pollard LW. Atrial fibrillation in flying personnel. Circulation. 1964;29:694–701
[Abstract/Free Full Text] - Close JB, Evans DW, Bailey SM. Persistent idiopathic atrial fibrillation. Its prognosis after clinical diagnosis. J R Coll Gen Pract. 1979;29:547–549[Medline]
- Davidson E, Rotenbert Z, Weinberger I, Fuchs J, Agmon J. Diagnosis and characteristics of idiopathic atrial fibrillation. Chest. 1989;95:1048–1050
[Abstract/Free Full Text] - Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of idiopathic atrial fibrillation. JAMA. 1985;254:3449–3453[Abstract]
- Kopecky SL, Gersh BJ, McGoon MD. The natural history of idiopathic atrial fibrillation. N Engl J Med. 1987;317:669–674[Abstract]
- Rostagno C, Bacci F, Martelli M, Naldoni A, Bertini G, Gensini G. Clinical course of idiopathic atrial fibrillation since first symptomatic arrhythmic episode. Am J Cardiol. 1995;76:837–839[CrossRef][ISI][Medline]
- Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannal WB, Levy D. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation. 1998;98:946–952
[Abstract/Free Full Text] - Ducimetière P, Cambien F, Richard JL, Rakotovao R. Coronary heart disease in middle-aged Frenchmen. Lancet. 1980;:1346–1350
- International Classification of Diseases, 1965, Revision. Geneva, Switzerland, World Health Organization, 1968, 1, 3, 41
- Kulbertus HE, de Leval-Rutten F, Bartsch P, Petit JM. Atrial fibrillation in elderly, ambulatory patients. Kulbertus HE, Olsson SB, Schlepper M. Atrial fibrillation. Môlndal: Lindgren-Soner; 1981. p. 148–157
- Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA. 1981;245:1540–1544[Abstract]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. J. Camm and J. A. Reiffel Defining endpoints in clinical trials on atrial fibrillation Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H55 - H78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Aliot and J. N. Ruskin Controversies in ablation of atrial fibrillation Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H32 - H54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Molina, L. Mont, J. Marrugat, A. Berruezo, J. Brugada, J. Bruguera, C. Rebato, and R. Elosua Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study Europace, May 1, 2008; 10(5): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Asbach, M. Olschewski, T. S. Faber, M. Zehender, C. Bode, and M. Brunner Mortality in patients with atrial fibrillation has significantly decreased during the last three decades: 35 years of follow-up in 1627 pacemaker patients Europace, April 1, 2008; 10(4): 391 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Taggar, F. Marin, and G. Y.H. Lip Mortality in patients with atrial fibrillation: improving or not? Europace, April 1, 2008; 10(4): 389 - 390. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Taggar and G. Y.H. Lip Risk predictors for lone atrial fibrillation Europace, January 1, 2008; 10(1): 6 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA) Eur. Heart J., November 2, 2007; 28(22): 2803 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Porchay-Balderelli, F. Pean, N. Bellili, R. Jaziri, M. Marre, F. Fumeron, and for the DIABHYCAR Study Group The CETP TaqIB Polymorphism Is Associated With the Risk of Sudden Death in Type 2 Diabetic Patients Diabetes Care, November 1, 2007; 30(11): 2863 - 2867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association Europace, November 1, 2007; 9(11): 1006 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jais and D. L. Packer Ablation vs. drug use for atrial fibrillation Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G26 - G34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jais, D.C. Shah, M. Hocini, L. Macle, K.-J. Choi, M. Haissaguerre, and J. Clementy Radiofrequency ablation for atrial fibrillation Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H34 - H39. [Abstract] [PDF]
|
|
|
|
 |
|
 A Wakai and J O O'Neill Emergency management of atrial fibrillation Postgrad. Med. J., June 1, 2003; 79(932): 313 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jais, R. Weerasooriya, D. C. Shah, M. Hocini, L. Macle, K.-J. Choi, C. Scavee, M. Haissaguerre, and J. Clementy Ablation therapy for atrial fibrillation (AF): Past, present and future Cardiovasc Res, May 1, 2002; 54(2): 337 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Falk Atrial Fibrillation N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078. [Full Text] [PDF]
|
|
|
|
 |
|
 D De Bacquer, G De Backer, and M Kornitzer Prevalences of ECG findings in large population based samples of men and women Heart, December 1, 2000; 84(6): 625 - 633. [Abstract] [Full Text]
|
|
|
|
|
|
J.S. Alpert Atrial fibrillation: a growth industry in the 21st century Eur. Heart J., August 1, 2000; 21(15): 1207 - 1208. [PDF]
|
|
|
|
|
|
G.Y.H. Lip Atrial fibrillation and mortality Eur. Heart J., November 1, 1999; 20(21): 1525 - 1527. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||